Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Shrivastava

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 8, 2021
Synthesis of novel 1,2,4-trioxanes and antimalarial evaluation against multidrug-resistant Plasmodium yoelii nigeriensisMonika Shukla, Mohammad Hassam, Dinesh Kumar Yadav, et al.
European Journal of Medicinal Chemistry|December 23, 2018
Current scenario of artemisinin and its analogues for antimalarial activityAkriti Kumari, Manvika Karnatak, Davinder Singh, et al.
Molecular Microbiology|August 19, 2020
Mutations in enterobacterial common antigen biosynthesis restore outer membrane barrier function in Escherichia coli tol-pal mutantsXiang'Er Jiang, Wee Boon Tan, Rahul Shrivastava, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2012
In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine infection modelVivek Kr Kashyap, Ravi Kr Gupta, Rahul Shrivastava, et al.
Respiratory Medicine|August 4, 2025
Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometasone furoate dry powder inhaler in Indian asthma patientsChintan Patel, Vaishal Sheth, Ravi Koppula, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2021
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitalsSachin S Bhagwat, Nicholas J Legakis, Tilemachos Skalidis, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2020
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3Sachin S Bhagwat, Periasamy Hariharan, Prashant R Joshi, et al.
Frontiers in Public Health|April 11, 2022
Sero-Surveillance to Monitor the Trend of SARS-CoV-2 Infection Transmission in India: Study Protocol for a Multi Site, Community Based Longitudinal Cohort StudyDivya Nair, Reshma Raju, Sudipto Roy, et al.
Mbio|October 27, 2023
Transcending the challenge of evolving resistance mechanisms in <i>Pseudomonas aeruginosa</i> through β-lactam-enhancer-mechanism-based cefepime/zidebactamAndrea M Hujer, Steven H Marshall, Andrew R Mack, et al.
Frontiers in Digital Health|February 18, 2026
Identification and validation of respiratory virus immunization using natural language processingKevin A Wilson, John J Riddles, Andrew C Hill, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|August 8, 2021
Synthesis of novel 1,2,4-trioxanes and antimalarial evaluation against multidrug-resistant Plasmodium yoelii nigeriensisMonika Shukla, Mohammad Hassam, Dinesh Kumar Yadav, et al.
European Journal of Medicinal Chemistry|December 23, 2018
Current scenario of artemisinin and its analogues for antimalarial activityAkriti Kumari, Manvika Karnatak, Davinder Singh, et al.
Molecular Microbiology|August 19, 2020
Mutations in enterobacterial common antigen biosynthesis restore outer membrane barrier function in Escherichia coli tol-pal mutantsXiang'Er Jiang, Wee Boon Tan, Rahul Shrivastava, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2012
In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine infection modelVivek Kr Kashyap, Ravi Kr Gupta, Rahul Shrivastava, et al.
Respiratory Medicine|August 4, 2025
Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometasone furoate dry powder inhaler in Indian asthma patientsChintan Patel, Vaishal Sheth, Ravi Koppula, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2021
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitalsSachin S Bhagwat, Nicholas J Legakis, Tilemachos Skalidis, et al.
The Journal of Antimicrobial Chemotherapy|August 11, 2020
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3Sachin S Bhagwat, Periasamy Hariharan, Prashant R Joshi, et al.
Frontiers in Public Health|April 11, 2022
Sero-Surveillance to Monitor the Trend of SARS-CoV-2 Infection Transmission in India: Study Protocol for a Multi Site, Community Based Longitudinal Cohort StudyDivya Nair, Reshma Raju, Sudipto Roy, et al.
Mbio|October 27, 2023
Transcending the challenge of evolving resistance mechanisms in <i>Pseudomonas aeruginosa</i> through β-lactam-enhancer-mechanism-based cefepime/zidebactamAndrea M Hujer, Steven H Marshall, Andrew R Mack, et al.
Frontiers in Digital Health|February 18, 2026
Identification and validation of respiratory virus immunization using natural language processingKevin A Wilson, John J Riddles, Andrew C Hill, et al.
Pageof 9